Lab-made virus is safer to work with, can aid efforts to find drugs, vaccines. Airborne…
Browsing: COVID-19
COVID-19, caused by the SARS-CoV-2 coronavirus, is a global infectious disease that emerged in late 2019 and reshaped public health, science, and society. It primarily affects the respiratory system but can impact multiple organs, leading to a wide range of symptoms from mild illness to severe complications. The pandemic spurred unprecedented scientific collaboration, driving rapid advances in virology, epidemiology, and vaccine development, including mRNA technology. Research into COVID-19 continues to reveal insights into viral evolution, immune response, long COVID, and pandemic preparedness. Its legacy continues to influence healthcare systems, global health policy, and biomedical innovation worldwide.
A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being…
Using computational analysis, research team shows how ebselen binds to SARS CoV-2 main four protease.…
Patients with undiagnosed flu symptoms who actually had COVID-19 last winter were among thousands of…
Filter “paper” made from titanium oxide nanowires is capable of trapping pathogens and destroying them…
Exactly how viruses replicate is a complex puzzle with many missing pieces. And in the…
Chicago Booth’s Ayelet Fishbach offers advice for dealing with loneliness and COVID-19. The COVID-19 pandemic…
Massive, rapid production of vaccines to fight COVID-19 will require firms to share know-how not…
University of Chicago researchers launch projects exploring health disparities, machine learning. The COVID-19 pandemic has…
As scientists around the world rush to learn more about COVID-19, several labs at the…
Sweden’s policy of allowing the controlled spread of COVID-19 viral infection among the population has…
Designed and assembled by experts from across the Institute, the facility should enable testing of…
There was a higher incidence and severity of physical intimate partner violence (IPV) among patients…
Vaccine shows promise in mouse studies and is currently being evaluated in Phase 3 clinical…
To date, Congress has authorized roughly $3 trillion in COVID-19 relief assistance — the largest…
Vaccine prevents pneumonia, elicits high levels of protective antibodies in mice. An experimental vaccine is…
Two Phase 3, randomized, placebo-controlled, double-blind clinical trials testing whether experimental monoclonal antibodies (mAbs) can…
Published in JAMA Internal Medicine, research conducted at an EPA facility on the UNC-Chapel Hill…